Aug 2017 $2 M No. 5 $2 to $10 million 1
Biocept Inc.: Raise no. 5, Aug 2017 × Investors in this round 1 investor had bought by the notice of Aug 14, 2017: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $4 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees $110,000
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Lyle E. Arnold · Executive Officer Michael E. Terry · Executive Officer Michael Nall · Executive Officer, Director Tim Kennedy · Executive Officer Veena Singh · Executive Officer Bruce E. Gerhardt · Director Bruce E. Huebner · Director David Hale · Director Ed E. Neff · Director Ivor E. Royston · Director M. Faye Wilson · Director Marsha A. Chandler · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On fees: “Represents a 5% fee paid pursuant to a referral agreement.”On the amounts: “Total Offering Amount includes up to $2,151,958.50 to be received upon the exercise of warrants to purchase Common Stock; such warrants have not yet been exercised.”Signed by Timothy Kennedy, Chief Financial Officer. Source: SEC Form D, newest notice filed Aug 14, 2017. Read the notice at the SEC .
equity, options SEC Dec 2015 $1 M No. 4 Under $2 million 1
Biocept Inc.: Raise no. 4, Dec 2015 × Investors in this round 1 investor had bought by the notice of Dec 23, 2015: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $15 M offered; $14 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Lyle W Arnold · Executive Officer Mark W Foletta · Executive Officer Michael W Nall · Executive Officer, Director Raaj W Trivedi · Executive Officer Veena W Singh · Executive Officer Bruce A Huebner · Director Bruce E Gerhardt · Director David F Hale · Director Edward A Neff · Director Ivor A Royston · Director M Faye Wilson · Director Marsha A Chandler · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Mark Foletta, Interim CFO. Source: SEC Form D, newest notice filed Dec 23, 2015. Read the notice at the SEC .
equity SEC Feb 2011 $1 M No. 3 Under $2 million 1
Biocept Inc.: Raise no. 3, Feb 2011 × Investors in this round 1 investor had bought by the notice of Feb 16, 2011: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $6 M offered; $5 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in California People named in the notice Farideh Bischoff · Executive Officer · Interim Chief Scientific Officer Meg McGilley · Executive Officer Todd Johnson · Executive Officer Bruce Gerhardt · Director Claire Reiss · Director Daniel Petree · Director Edward Dennis · Director Edward Neff · Director Faye Wilson · Director Ivor Royston · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Amount listed above under Total Offering Amount includes $1,000,000 receivable by the Issuer upon the exercise of warrants to purchase shares of the Issuers Convertible Preferred Stock. Such warrants have not been exercised.”On a merger: “Securities offered consist of promissory notes convertible into shares of convertible preferred stock, warrants exercisable for shares of convertible preferred stock and the common stock underlying the convertible preferred stock.”Signed by Meg McGilley, Cfo. Source: SEC Form D, newest notice filed Feb 16, 2011. Read the notice at the SEC .
debt, options SEC Aug 2010 $2 M No. 2 $2 to $10 million 1
Biocept Inc.: Raise no. 2, Aug 2010 × Investors in this round 1 investor had bought by the notice of Aug 12, 2010: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $7 M offered; $5 M still to sell
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in California People named in the notice Stephen Coutts · Executive Officer, Director Bruce Gerhardt · Director Claire Reiss · Director Daniel Petree · Director Edward Dennis · Director Edward Neff · Director Faye Wilson · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Series BB Preferred Stock Financing”Signed by Stephen M. Coutts, President & CEO. Source: SEC Form D, newest notice filed Aug 12, 2010. Read the notice at the SEC .
equity SEC Mar 2010 $4 M No. 1 $2 to $10 million 4
Biocept Inc.: Raise no. 1, Mar 2010 × Investors in this round 4 investors had bought by the notice of Mar 29, 2010: 4 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $4 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in California People named in the notice Jennifer K. Crittenden · Executive Officer Stephen Coutts · Executive Officer, Director Claire Reiss · Director Daniel Petree · Director Edward Dennis · Director Edward Neff · Director Faye Wilson · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Jennifer K. Crittenden, Cfo. Source: SEC Form D, newest notice filed Mar 29, 2010. Read the notice at the SEC .
equity SEC